GnRH Agonists and Antagonists in Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5968|3|6|399-410

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.3, Iss.6, 2003-11, pp. : 399-410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women

By Robertson J.F.R.   Blamey R.W.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 861-869

Elsevier

Access to resources Recommend Favorite

Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer

By Torrisi Rosalba  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 431-441

Springer Publishing Company

Access to resources Recommend Favorite

Protection of ovarian function by GnRH agonists during chemotherapy: A meta-analysis

By        

International Journal of Oncology, Vol. 44, Iss. 4, 2014-01 ,pp. : 1335-1340

Spandidos Publications

Access to resources Recommend Favorite

GnRH analogs reduce invasiveness of human breast cancer cells

By Alten Julia   Fister Stefanie   Schulz Hiltrud   Viereck Volker   Frosch Karl-Heinz   Emons Günter   Gründker Carsten  

Breast Cancer Research and Treatment, Vol. 100, Iss. 1, 2006-11 ,pp. : 13-21

Springer Publishing Company

Access to resources Recommend Favorite

Antitumor Effect of GnRH Agonist in Epithelial Ovarian Cancer

By Kim J.H.   Park D.C.   Kim J.W.   Choi Y.K.   Lew Y.O.   Kim D.H.   Jung J.K.   Lim Y.A.   Namkoong S.E.  

Gynecologic Oncology, Vol. 74, Iss. 2, 1999-08 ,pp. : 170-180

Elsevier

Access to resources Recommend Favorite